What is Intrauterine Growth Restriction (IUGR)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Definition of Intrauterine Growth Restriction (IUGR)

Intrauterine growth restriction (IUGR), now preferably termed fetal growth restriction (FGR), is defined as an estimated fetal weight (EFW) or abdominal circumference (AC) below the 10th percentile for gestational age. 1, 2, 3

Core Diagnostic Criteria

  • Standard threshold: FGR is diagnosed when EFW or AC falls below the 10th percentile for gestational age, as established by the American College of Obstetricians and Gynecologists 1, 2, 3

  • Severe FGR: Defined as EFW below the 3rd percentile, representing the most critical category with stillbirth rates up to 2.5% 1, 2, 3

Distinguishing IUGR from Related Terms

IUGR versus Small for Gestational Age (SGA): While these terms are often used interchangeably, important distinctions exist 4, 5:

  • FGR/IUGR represents a pathological condition where the fetus fails to achieve its genetic growth potential due to placental insufficiency or other pathologic processes 4, 6

  • SGA is a statistical definition referring to birthweight below the 10th percentile, which may include constitutionally small but healthy infants 3, 5

  • The Society for Maternal-Fetal Medicine recommends using "fetal growth restriction (FGR)" for prenatal diagnosis and reserving "small for gestational age (SGA)" for postnatal classification 3

Pathophysiologic Basis

True IUGR represents a pathological condition where the placenta fails to deliver adequate oxygen and nutrients to the developing fetus, distinguishing it from constitutional smallness 7, 5:

  • The condition results from various etiologies including maternal, placental, fetal, and genetic factors 4

  • Uteroplacental vascular insufficiency is one of the main causes, leading to chronic oxygen and nutrient deprivation 6

  • The growth-restricted fetus displays circulatory adaptations to preserve oxygen and nutrient supply to vital organs (brain, heart, adrenals) 6

Clinical Significance and Risk Stratification

Fetuses below the 10th percentile face doubled stillbirth risk (approximately 1.5% compared to 0.7% in normally growing fetuses), along with increased risks of severe acidosis, low Apgar scores, and NICU admissions 1, 3:

  • Below the 5th percentile, stillbirth rates increase to 2.5% 3

  • Below the 3rd percentile (severe FGR), stillbirth rates reach up to 2.5% regardless of other findings 3

  • Preterm FGR compounds risk with 2- to 5-fold increased perinatal death rates compared to term FGR 1

Confirming Pathological Growth Restriction

Additional parameters beyond size alone help distinguish pathological FGR from constitutional smallness 2, 3:

  • Abnormal umbilical artery Doppler: Elevated pulsatility index, resistance index, or absent/reversed end-diastolic velocity confirms placental insufficiency 2, 3

  • Reduced growth velocity: AC change <5mm over 14 days or >30% reduction in growth velocity indicates progressive pathology 2, 3

  • Oligohydramnios: Suggests chronic placental dysfunction 3

  • Abnormal middle cerebral artery Doppler or cerebroplacental ratio: Indicates fetal brain-sparing redistribution 3

Timing Classification

  • Early-onset FGR: Diagnosed at <32 weeks gestation, often associated with more severe placental insufficiency and may warrant genetic testing 1, 2

  • Late-onset FGR: Diagnosed at ≥32 weeks gestation 2

Long-Term Implications

IUGR is linked with lifelong health consequences beyond the perinatal period 8, 7:

  • Impaired intellectual performance in childhood 8

  • Adult diseases including hypertension, obesity, cardiovascular disease, metabolic syndrome, diabetes, respiratory diseases, and chronic kidney disease 8, 7

  • Neurodevelopmental handicaps and developmental origins of health and disease 5

References

Guideline

Fetal Growth Restriction Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Cut-off for Diagnosing IUGR in Anomaly Scan

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Fetal Growth Restriction Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Intrauterine growth restriction - part 1.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2016

Research

Intrauterine Growth Restriction: Antenatal and Postnatal Aspects.

Clinical medicine insights. Pediatrics, 2016

Research

Long-term implications of fetal growth restriction.

World journal of clinical cases, 2023

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.